Skip to main content

Table 3 Distribution of clinicopathological parameters in resected tumors by sex

From: Sex and gender differences in treatment intention, quality of life and performance status in the first 100 patients with periampullary cancer enrolled in the CHAMP study

 

Women

Men

N(%)

7 (18%)

18 (72%)

Tumour size mm

 Median (range)

25.5 (10.0–33.0)

28.5 (14.0–45.0)

Missing

1

2

Tumour location

 Caput

4 (57.1)

16 (77.7)

 Corpus

1 (14.3)

1 (5.6)

 Cauda

2 (28.6)

2 (11.1)

 Othera

0

2 (11.1)

T stage

 T1-T2

5 (71.4)

15 (83.3)

 T3-T4

2 (28.6)

3 (16.7)

Resected lymph nodes

 < 15

3 (42.9)

4 (22.2)

  > 15

4 (57.1)

14 (77.8)

Metastatic lymph nodes 

 0

1 (14.3)

7 (38.9)

 1–3

2 (28.6)

6 (33.3)

  > 3

3 (57.1)

5 (27.8)

R status

 0

4 (57.1)

7 (38.9)

 1

3 (42.9)

11 (61.1)

Tumour Grade

 Well-moderate

1 (14.3)

3 (16.7)

 Poor

4 (57.1)

8 (44.4)

Missing

2 (28.6)

7 (38.9)

Vascular invasion

 Absent

3 (42.9)

13 (72.2)

 Present

4 (57.1)

5 (27.8)

Lymphatic invasion

 Absent

3 (42.9)

9 (50.0)

 Present

4(57.1)

9 (50.0)

Perineural invasion

 Absent

2 (28.6)

6 (33.3)

 Present

5 (71.4)

12 (66.7)

Surgical procedure

 Whipple

4 (57.1)

15 (83.3)

 Distal pancreatectomy

3 (42.9)

3 (16.7)

  1. a1 Distal cholangiocarcinoma, 1 ampullary adenocarcinoma. Non-parametric test for continuous variables and X2 test for categorical variables